Arvinas, Inc. (ARVN) analyst actions
Rating and price-target actions on ARVN in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ARVN overview →
3 measured ARVN analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Arvinas, Inc. (ARVN) And Encourages Shareholders to Reach Out | Press release | -0.16% | -1.86% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Arvinas, Inc. (ARVN) And Encourages Stockholders to Reach Out | Press release | -1.54% | +2.42% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Arvinas, Inc. (ARVN) And Encourages Stockholders to Reach Out | Press release | -1.11% | +5.05% |
Keep exploring
More ARVN: earnings → · SEC filings → · ARVN overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ROCHE HOLDING LTD S/ADR (RHHBY) | 449 | +0.03% | 52% |
| CareDx, Inc. (CDNA) | 443 | -0.11% | 47% |
| Jaguar Health, Inc. (JAGX) | 442 | -0.38% | 41% |
| BOVIE MEDICAL (BVX) | 441 | 0.00% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.